Indolyl derivatives
US7265149B2 · kind B2 · utility
1Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 2005 |
| Grant date | Sep 4, 2007 |
| Priority date | — |
| Expiry date | Jul 12, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds of the formula I:wherein one of R6, R7 and R8 isand R1 to R15 and n are as defined in the description, and all enantiomers and pharmaceutically acceptable salts and/or esters thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPAR δ and/or PPARα agonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.